Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review

Authors

Institutions

Publication Details

Journal
Open Heart
Published
2026-01-01
DOI
https://doi.org/10.1136/openhrt-2025-003867
Primary Topic
IL-33, ST2, and ILC Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review

Renato D. Lópes, Shehzeen Lalani, Kristin Newby, Pishoy Gouda et al.
Open Heart
IL-33, ST2, and ILC Pathways
article

Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review

Renato D. Lópes, Shehzeen Lalani, Kristin Newby, Pishoy Gouda, Schuyler Jones
article en

Abstract

No abstract available for this paper.
Open HeartVol. 13(1)
University of Alberta (CA), Clinical Research Institute (US), Duke Medical Center (US), McGill University (CA)
Reduced inequalities
Openalex Percentile: Top 95%
IL-33, ST2, and ILC Pathways
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review — Renato D. Lópes, Shehzeen Lalani, et al. · Open Heart (2026) | TGRS Research Map | TGRS